Veru's experimental drug helps Wegovy patients preserve muscle in study (updated)

Veru

27/01/2025 11:54

(Adds trial details in paragraphs 3,4)
       Jan 27 (Reuters) - Veru  VERU.O  said on Monday its
experimental drug, in combination with Novo Nordisk's  NOVOb.CO 
weight-loss treatment Wegovy, helped preserve muscle in older
patients with obesity, meeting the main goal of a mid-stage
study. 
        The study was testing Veru's oral drug, enobosarm, in
patients aged 60 and above. The drug targets androgen hormones,
which play a role in body development and reproductive health. 
        Patients who received the drug in combination with
Wegovy lost 71% less lean muscle on average than those who
received Wegovy alone, the company said. 

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun
Koyyur and Devika Syamnath)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))